JPWO2022145408A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022145408A5
JPWO2022145408A5 JP2022573078A JP2022573078A JPWO2022145408A5 JP WO2022145408 A5 JPWO2022145408 A5 JP WO2022145408A5 JP 2022573078 A JP2022573078 A JP 2022573078A JP 2022573078 A JP2022573078 A JP 2022573078A JP WO2022145408 A5 JPWO2022145408 A5 JP WO2022145408A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
group
atom
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022573078A
Other languages
English (en)
Japanese (ja)
Other versions
JP7741820B2 (ja
JPWO2022145408A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/048476 external-priority patent/WO2022145408A1/ja
Publication of JPWO2022145408A1 publication Critical patent/JPWO2022145408A1/ja
Publication of JPWO2022145408A5 publication Critical patent/JPWO2022145408A5/ja
Application granted granted Critical
Publication of JP7741820B2 publication Critical patent/JP7741820B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022573078A 2020-12-28 2021-12-27 セロトニン受容体結合活性を有する環状アミン誘導体 Active JP7741820B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020218179 2020-12-28
JP2020218179 2020-12-28
PCT/JP2021/048476 WO2022145408A1 (ja) 2020-12-28 2021-12-27 セロトニン受容体結合活性を有する環状アミン誘導体

Publications (3)

Publication Number Publication Date
JPWO2022145408A1 JPWO2022145408A1 (https=) 2022-07-07
JPWO2022145408A5 true JPWO2022145408A5 (https=) 2024-12-13
JP7741820B2 JP7741820B2 (ja) 2025-09-18

Family

ID=82260763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022573078A Active JP7741820B2 (ja) 2020-12-28 2021-12-27 セロトニン受容体結合活性を有する環状アミン誘導体

Country Status (4)

Country Link
US (1) US20240083872A1 (https=)
JP (1) JP7741820B2 (https=)
TW (1) TW202241856A (https=)
WO (1) WO2022145408A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202328148A (zh) * 2021-09-22 2023-07-16 日商塩野義製藥股份有限公司 具有血清素受體結合活性之螺雜環衍生物
WO2024067304A1 (zh) * 2022-09-28 2024-04-04 瀚远医药有限公司 一种具有Sigma2和5HT2A抑制活性的化合物及用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0585500A1 (en) * 1992-09-04 1994-03-09 Merrell Dow Pharmaceuticals Inc. Diaryl piperazineacetamides as antimuscarinic agents
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
MX2020001757A (es) * 2017-08-21 2020-09-07 Acadia Pharm Inc Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades.
CN113549006B (zh) * 2020-04-26 2023-07-21 江苏恩华药业股份有限公司 一种酰胺衍生物及其应用
CN114728933B (zh) * 2020-07-22 2023-06-16 山东绿叶制药有限公司 5-ht2a受体抑制剂或反向激动剂及其制备方法和应用

Similar Documents

Publication Publication Date Title
RU2375363C2 (ru) Пирролотриазиновые производные анилина, полезные в качестве ингибиторов киназы
JP2018507877A5 (https=)
JP2009536620A5 (https=)
JPWO2020085493A5 (https=)
JP2019094345A5 (https=)
JP2008528467A5 (https=)
JPWO2022145408A5 (https=)
JP2013056930A5 (https=)
JP2009524670A5 (https=)
JP2007519694A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2009513703A5 (https=)
JP2012508252A5 (https=)
JP2011507854A5 (https=)
JP2004517087A5 (https=)
JP2016519685A5 (https=)
JP2014520108A5 (https=)
JP2009543771A5 (https=)
JP2011503199A5 (https=)
JP2010527984A5 (https=)
JP2015535851A5 (https=)
JP2020507566A5 (https=)
JP2010527985A5 (https=)
RU2009119181A (ru) Гетероциклические соединения и их применение в качестве ингибиторов гликогенсинтаза-киназы-3
JP2017500321A5 (https=)